Aim: Rare variations are suggested to play a role in the genetic etiology of schizophrenia; to further investigate their role, we performed a three-stage study in a Japanese population.
S CHIZOPHRENIA (MIM 181500) is a severe psychiatric disorder characterized by positive symptoms (hallucinations and delusions), negative symptoms (avolition and blunted affect), and cognitive impairment. 1 It is a complex disorder caused by both genetic and environmental factors and their interactions and has a high heritability of approximately 80%. 1 The genetic complexity of schizophrenia involves large numbers of risk alleles ranging from common alleles with small effect sizes to rare alleles with large effect sizes. 2 A meta-analysis of genome-wide association studies has identified over 100 common loci associated with schizophrenia. 3 Recent studies have also identified several rare copy number variations associated with schizophrenia. 4, 5 Whole-exome sequencing (WES) studies have revealed that rare sequence variations and small insertions or deletions contribute substantially to schizophrenia liability. 6, 7 A recent meta-analysis of WES studies showed a significant association of rare loss-of-function (nonsense, splice site, and frameshift) variations in the SETD1A gene with schizophrenia in 4264 patients, 9343 controls, and 1077 parent-affected offspring trios.
8 SETD1A was also reported to have two de novo loss-of-function variations and one de novo functional synonymous variation in 1021 schizophrenia probands, which was more than expected after genome-wide correction. 9 Of note, there was an exome-wide burden of genedisruptive and putatively protein-damaging ultrarare variations (dURV) that were unique to individuals in 4877 patients with schizophrenia compared to 6203 controls. 10 The elevation rates of dURV in schizophrenia were several times larger than those of de novo dURV, suggesting that the observed elevation rates of dURV in schizophrenia arose mostly from inherited variations. 10 To further investigate the role of rare variations in the genetic etiology of schizophrenia, we performed a three-stage study in a Japanese population. In the first stage, we performed WES of two parent-affected offspring trios. A rare frameshift variation (L116fsX) in the FBXO18 gene was recurrently identified in both trios. In the second stage, we resequenced the FBXO18 coding region in 96 patients. In the third stage, we tested rare non-synonymous FBXO18 variations, identified by WES and resequencing, for association with schizophrenia in two independent populations comprising a total of 1376 patients and 1496 controls.
METHODS Participants
This study was approved by the Ethics Committee of each participating institute, and written informed consent was obtained from all participants. All participants were of Japanese descent.
Two parent-affected offspring trios ( Fig. 1 ) were included in a WES study. Participants were diagnosed according to DSM-IV criteria, as previously described.
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The FBXO18 coding region was resequenced in 96 patients with schizophrenia (52 men and 44 women; mean age 37.8 AE 11.6 years). These patients were diagnosed according to DSM-IV criteria by at least two experienced psychiatrists, as previously described. 11 These patients did not overlap with those in the case-control study.
Two independent case-control samples comprising a total of 1378 patients and 1496 controls were used for the association study. The Niigata sample comprised 639 patients with schizophrenia (342 men and 297 women; mean age 40.1 AE 13.8 years) and 674 control individuals (343 men and 331 women; mean age 38.3 AE 10.9 years), who were recruited from Niigata University. 11 The Kobe sample comprised 739 patients with schizophrenia (402 men and 337 women; mean age 53.0 AE 14.9 years) and 822 control individuals (377 men and 445 women; mean age 52.7 AE 18.5 years), who were recruited from Kobe University. 12 Psychiatric assessment of each participant was conducted, as previously described. 11, 12 In brief, the patients were diagnosed according to DSM-IV or DSM-5 criteria by at least two experienced psychiatrists. Controls were mentally healthy individuals, with no personal or family history (within first-degree relatives) of psychiatric disorders.
WES
WES was performed on two trios, as previously described. 13, 14 In brief, exome libraries were prepared using the SureSelect Human All Exon V5 Kit (Agilent, Santa Clara, CA, USA) and sequenced using the HiSeq2000 system (Illumina, San Diego, CA, USA). The raw sequence reads were cleaned by removing adaptor sequences and low-quality reads using CUTDAPT v1.21 (https://cutadapt.readthedocs. io/en/stable/) and FASTX-TOOLKIT v0.0.13 (http:// hannonlab.cshl.edu/fastx_toolkit/), respectively. Paired-end sequence reads were extracted using cmpfastq_pe (http://compbio.brc.iop.kcl.ac.uk/ software/cmpfastq.php) and mapped against the reference human genome (UCSC hg19) using the Burrows-Wheeler ALIGNER v0.5.9 (http://bio-bwa. sourceforge.net/). Polymerase chain reaction duplicates were removed using PICARD v1.93 (http:// picard.sourceforge.net/). Variation calling was performed using the GENOME ANALYSIS TOOLKIT v1.6-9 (http://www.broadinstitute.org/gatk/). Variations were annotated using SNPEFF v3.6c (http://snpeff. sourceforge.net/).
To prioritize variations, we applied several filtering steps (Table 1) . First, we filtered out variations with less than 10 × coverage. Second, we included variations called in an affected offspring in each family. Third, we included 'HIGH' Effect_Impact variations predicted using SnpEff. Fourth, we included rare variations defined as variations with mutant allele frequency <0.01 in the HUMAN GENETIC VARIATION DATABASE v1.41 (HGVD; http://www.genome.med. kyoto-u.ac.jp/SnpDB/). Fifth, we included variations that followed inheritance models, including autosomal-dominant, autosomal-recessive, X-linked, or de novo models. Finally, we selected a rare frameshift variation (L116fsX) in the FBXO18 gene that was recurrently identified in two families.
To validate the FBXO18 L116fsX variation, Sanger sequencing was performed using a 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA), as previously described. 15 Detailed information on Sanger sequencing is available upon request.
Resequencing the FBXO18 coding region FBXO18 coding regions (RefSeq NM_032807) were resequenced in 96 patients using Sanger sequencing. Primer sequences for amplification are listed in Table S1 . Detailed information on the amplification conditions is available upon request.
Case-control study
To determine if rare non-synonymous FBXO18 variations identified by WES and resequencing contribute to the genetic etiology of schizophrenia, we performed a case-control study in two independent populations comprising a total of 1378 patients and 1496 controls. All variations were genotyped using the TaqMan 5 0 -exonuclease assay (Applied Biosystems; Table S2), as previously described. 
Statistical analysis
Deviations from Hardy-Weinberg equilibrium were tested using the χ 2 -test for goodness-of-fit. Allelic associations were tested using Fisher's exact test. We performed a meta-analysis in a random-effect model using EZR v1.30 (https://cran.r-project.org/web/ packages/RcmdrPlugin.EZR/index.html). A power calculation was performed using the Genetic Power Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/). Power was estimated using α = 0.05, and assuming a disease prevalence of 0.01.
RESULTS
A total of 181 809 and 183 325 sequence variations were called by WES in family #1 and family #2, respectively (Table 1) . After several filtering steps, we prioritized nine rare frameshift and nonsense variations in each family (Table S3 ). Among these variations, a rare frameshift variation (L116fsX) in the FBXO18 gene was recurrently identified in family #1 and family #2. The mutant allele was transmitted from an unaffected mother in family #1 and an unaffected father in family #2 to an affected offspring (Fig. 1a,b, respectively) .
Resequencing the FBXO18 coding region in 96 patients identified nine variations ( Fig. 2 ; Table S4 ). Of these, three were rare non-synonymous variations (Table 2) : V15L (g.5937039G > C; rs1435-63006), L116fsX (g.5948034delC; rs780958035), and V1006I (g.5978452G > A; rs141977640).
Next, we performed a case-control study to assess associations of the three rare non-synonymous FBXO18 variations with schizophrenia using two independent populations (Table 3) . Genotype distributions of the variations did not deviate significantly from Hardy-Weinberg equilibrium in patient or control groups of the Niigata or Kobe samples, with the exception of L116fsX in the control group of the Niigata sample. The three rare nonsynonymous FBXO18 variations were not significantly associated with schizophrenia in the Niigata or Kobe samples. In the meta-analysis, there were no significant associations between these variations and schizophrenia.
DISCUSSION
In the WES of two parent-affected offspring trios, we prioritized 17 rare frameshift and nonsense variations that were all inherited (i.e. not de novo). Recent WES studies have demonstrated that rare de novo variations contribute to the genetic etiology of schizophrenia. 6, 9 We performed WES in only two trios and prioritized 'HIGH' Effect_Impact variations; we may, therefore, have overlooked the role of rare de novo variations. Of note, when we included 'MOD-ERATE' and 'LOW' Effect_Impact variations we identified two rare de novo synonymous variations in family #1, but not in family #2, which we confirmed with Sanger sequencing. One was S68S (chr3: g.150659370T > C) in CLRN1 (RefSeq accession number, NM_052995). The other was Q423Q chr19: (g.3823346T > C) in ZFR2 (RefSeq accession number, NM_015174). We plan to investigate the role of rare de novo variations in the genetic etiology of schizophrenia with larger trios. In our present study, FBXO18 L116fsX was identified recurrently in both trios among our prioritized variations. Genomic DNA samples from unaffected siblings (II-1 in family #1, and II-2 and II-3 in family #2) were not available, and we were unable to confirm if they are heterozygous for FBXO18 L116fsX. Nevertheless, WES of two parent-affected offspring trios indicated that FBXO18 may be a potential candidate gene for schizophrenia.
FBXO18 encodes F-box DNA helicase 1 (FBH1), 16 which plays a critical role in the maintenance of genome stability. [17] [18] [19] Genomic instability is speculated to have a role in the pathogenesis of several diseases, including cancer and schizophrenia. 4, 20, 21 Indeed, FBXO18 deletion was found in 55% of 19 melanoma cell lines 22 and FBXO18-depleted immortalized melanocytes were prone to transformation induced by ultraviolet radiation. 22 In addition, five rare missense variations in FBXO18 (V15L, H33R, P88L, V552I, and I981P) were associated with breast cancer. 23 In contrast, the contribution of FBXO18 to the genetic etiology of schizophrenia remains poorly understood.
Resequencing FBXO18 coding regions in 96 patients identified three rare non-synonymous variations (V15L, L116fsX, and V1006I). The functional implications of these variations remain to be determined. However, some of these variations are predicted to be functional by in silico analysis ( Table 2 ). The functional effects of V15L and L116fsX were predicted to be 'damaging' by Sorting Intolerant from Tolerant (http://sift.bii.a-star.edu.sg/ index.html), whereas V15L was predicted to be 'benign' by Polymorphism Phenotyping v2 (http:// genetics.bwh.harvard.edu/pph2/). The Combined The case-control study did not provide statistical evidence for the association of rare nonsynonymous FBXO18 variations (V15L, L116fsX, and V1006I) with schizophrenia. This is consistent with an earlier WES study 7 reporting no significant association between schizophrenia and rare nonsynonymous FBXO18 variations (R732W and D938G) that are registered in Schizophrenia Exome Sequencing Genebook (http://atgu.mgh.harvard. edu/~spurcell/genebook/genebook.cgi?user=guest& cmd=overview), although each variation was identified in only one of 2536 patients but not in 2543 controls. Our sample size of 1378 patients and 1496 controls in the case-control study, although relatively large, may not provide adequate statistical power to detect an association between rare FBXO18 variations and schizophrenia. Indeed, a power calculation showed that the power was 0.60 if the genotypic relative risk was set to 2.0 for heterozygous risk allele carriers under the dominant model of inheritance, assuming a risk allele frequency of 0.005. Thus, we cannot exclude the possibility that the negative results we obtained are caused by type II errors. Further studies should be performed using sufficiently large sample sizes.
In conclusion, this study does not provide evidence for the contribution of rare FBOX18 variations to the genetic etiology of schizophrenia in the Japanese population.
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